Reuters logo
BRIEF-Pluristem extends trial for treatment of insufficient hematopoietic recovery
October 26, 2017 / 11:52 AM / in 2 months

BRIEF-Pluristem extends trial for treatment of insufficient hematopoietic recovery

Oct 26 (Reuters) - Pluristem Therapeutics Inc

* Following approval of israel’s ministry of health, Pluristem extends its trial of plx-r18 to treat insufficient Hematopoietic recovery after bone marrow transplant and opens clinical centers in Israel

* Pluristem therapeutics inc - ‍Israeli clinical sites will join an ongoing u.s. Phase I trial​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below